Literature DB >> 27166280

Reduced intestinal lipid absorption and body weight-independent improvements in insulin sensitivity in high-fat diet-fed Park2 knockout mice.

Diana K Costa1, Brydie R Huckestein2, Lia R Edmunds2, Max C Petersen3, Ali Nasiri1, Gina M Butrico1, Abudukadier Abulizi1, Daniel B Harmon2, Canying Lu2, Benjamin S Mantell2, Douglas J Hartman4, João-Paulo G Camporez1, Robert M O'Doherty5, Gary W Cline1, Gerald I Shulman6, Michael J Jurczak7.   

Abstract

Mitochondrial dysfunction is associated with many human diseases and results from mismatch of damage and repair over the life of the organelle. PARK2 is a ubiquitin E3 ligase that regulates mitophagy, a repair mechanism that selectively degrades damaged mitochondria. Deletion of PARK2 in multiple in vivo models results in susceptibility to stress-induced mitochondrial and cellular dysfunction. Surprisingly, Park2 knockout (KO) mice are protected from nutritional stress and do not develop obesity, hepatic steatosis or insulin resistance when fed a high-fat diet (HFD). However, these phenomena are casually related and the physiological basis for this phenotype is unknown. We therefore undertook a series of acute HFD studies to more completely understand the physiology of Park2 KO during nutritional stress. We find that intestinal lipid absorption is impaired in Park2 KO mice as evidenced by increased fecal lipids and reduced plasma triglycerides after intragastric fat challenge. Park2 KO mice developed hepatic steatosis in response to intravenous lipid infusion as well as during incubation of primary hepatocytes with fatty acids, suggesting that hepatic protection from nutritional stress was secondary to changes in energy balance due to altered intestinal triglyceride absorption. Park2 KO mice showed reduced adiposity after 1-wk HFD, as well as improved hepatic and peripheral insulin sensitivity. These studies suggest that changes in intestinal lipid absorption may play a primary role in protection from nutritional stress in Park2 KO mice by preventing HFD-induced weight gain and highlight the need for tissue-specific models to address the role of PARK2 during metabolic stress.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  PARK2; insulin resistance; lipid absorption; liver; mitophagy; obesity; small intestine

Mesh:

Substances:

Year:  2016        PMID: 27166280      PMCID: PMC4967148          DOI: 10.1152/ajpendo.00042.2016

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  53 in total

1.  Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease.

Authors:  Gerald I Shulman
Journal:  N Engl J Med       Date:  2014-12-04       Impact factor: 91.245

2.  Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat.

Authors:  S J Smith; S Cases; D R Jensen; H C Chen; E Sande; B Tow; D A Sanan; J Raber; R H Eckel; R V Farese
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

3.  A guide to analysis of mouse energy metabolism.

Authors:  Matthias H Tschöp; John R Speakman; Jonathan R S Arch; Johan Auwerx; Jens C Brüning; Lawrence Chan; Robert H Eckel; Robert V Farese; Jose E Galgani; Catherine Hambly; Mark A Herman; Tamas L Horvath; Barbara B Kahn; Sara C Kozma; Eleftheria Maratos-Flier; Timo D Müller; Heike Münzberg; Paul T Pfluger; Leona Plum; Marc L Reitman; Kamal Rahmouni; Gerald I Shulman; George Thomas; C Ronald Kahn; Eric Ravussin
Journal:  Nat Methods       Date:  2011-12-28       Impact factor: 28.547

4.  Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells.

Authors:  Kye-Young Kim; Mark V Stevens; M Hasina Akter; Sarah E Rusk; Robert J Huang; Alexandra Cohen; Audrey Noguchi; Danielle Springer; Alexander V Bocharov; Tomas L Eggerman; Der-Fen Suen; Richard J Youle; Marcelo Amar; Alan T Remaley; Michael N Sack
Journal:  J Clin Invest       Date:  2011-08-25       Impact factor: 14.808

5.  Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet.

Authors:  Megumi Hatori; Christopher Vollmers; Amir Zarrinpar; Luciano DiTacchio; Eric A Bushong; Shubhroz Gill; Mathias Leblanc; Amandine Chaix; Matthew Joens; James A J Fitzpatrick; Mark H Ellisman; Satchidananda Panda
Journal:  Cell Metab       Date:  2012-05-17       Impact factor: 27.287

6.  Ubiquitin is phosphorylated by PINK1 to activate parkin.

Authors:  Fumika Koyano; Kei Okatsu; Hidetaka Kosako; Yasushi Tamura; Etsu Go; Mayumi Kimura; Yoko Kimura; Hikaru Tsuchiya; Hidehito Yoshihara; Takatsugu Hirokawa; Toshiya Endo; Edward A Fon; Jean-François Trempe; Yasushi Saeki; Keiji Tanaka; Noriyuki Matsuda
Journal:  Nature       Date:  2014-06-04       Impact factor: 49.962

7.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

Review 8.  ApoA-IV: current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satiety.

Authors:  Alison B Kohan; Fei Wang; Chun-Min Lo; Min Liu; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-01-15       Impact factor: 4.052

9.  Circadian timing of food intake contributes to weight gain.

Authors:  Deanna M Arble; Joseph Bass; Aaron D Laposky; Martha H Vitaterna; Fred W Turek
Journal:  Obesity (Silver Spring)       Date:  2009-09-03       Impact factor: 5.002

10.  Dissociation of inositol-requiring enzyme (IRE1α)-mediated c-Jun N-terminal kinase activation from hepatic insulin resistance in conditional X-box-binding protein-1 (XBP1) knock-out mice.

Authors:  Michael J Jurczak; Ann-Hwee Lee; Francois R Jornayvaz; Hui-Young Lee; Andreas L Birkenfeld; Blas A Guigni; Mario Kahn; Varman T Samuel; Laurie H Glimcher; Gerald I Shulman
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

View more
  8 in total

Review 1.  Managing risky assets - mitophagy in vivo.

Authors:  Derek P Narendra
Journal:  J Cell Sci       Date:  2021-10-06       Impact factor: 5.235

2.  Adropin reduces blood glucose levels in mice by limiting hepatic glucose production.

Authors:  Dharendra Thapa; Bingxian Xie; Janet R Manning; Manling Zhang; Michael W Stoner; Brydie R Huckestein; Lia R Edmunds; Xueyang Zhang; Nikolaos L Dedousis; Robert M O'Doherty; Michael J Jurczak; Iain Scott
Journal:  Physiol Rep       Date:  2019-04

3.  Hepatic insulin sensitivity is improved in high-fat diet-fed Park2 knockout mice in association with increased hepatic AMPK activation and reduced steatosis.

Authors:  Lia R Edmunds; Brydie R Huckestein; Mario Kahn; Dongyan Zhang; Yanxia Chu; Yingze Zhang; Stacy G Wendell; Gerald I Shulman; Michael J Jurczak
Journal:  Physiol Rep       Date:  2019-11

4.  A high throughput, functional screen of human Body Mass Index GWAS loci using tissue-specific RNAi Drosophila melanogaster crosses.

Authors:  Thomas J Baranski; Aldi T Kraja; Jill L Fink; Mary Feitosa; Petra A Lenzini; Ingrid B Borecki; Ching-Ti Liu; L Adrienne Cupples; Kari E North; Michael A Province
Journal:  PLoS Genet       Date:  2018-04-02       Impact factor: 5.917

5.  Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance.

Authors:  Lia R Edmunds; Bingxian Xie; Amanda M Mills; Brydie R Huckestein; Ramya Undamatla; Anjana Murali; Martha M Pangburn; James Martin; Ian Sipula; Brett A Kaufman; Iain Scott; Michael J Jurczak
Journal:  Mol Metab       Date:  2020-07-10       Impact factor: 7.422

Review 6.  Role and Mechanisms of Mitophagy in Liver Diseases.

Authors:  Xiaowen Ma; Tara McKeen; Jianhua Zhang; Wen-Xing Ding
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

Review 7.  Mitophagy in the Pathogenesis of Liver Diseases.

Authors:  Po-Yuan Ke
Journal:  Cells       Date:  2020-03-30       Impact factor: 6.600

8.  Inclusion of endophenotypes in a standard GWAS facilitate a detailed mechanistic understanding of genetic elements that control blood lipid levels.

Authors:  Qianqian Zhang; Zexi Cai; Marie Lhomme; Goutam Sahana; Philippe Lesnik; Maryse Guerin; Merete Fredholm; Peter Karlskov-Mortensen
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.